GCM
ENFN

Ghisallo Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Ghisallo Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-125,000
Closed -$1.28M – 274
2022
Q2 		$1.28M Sell
125,000
-125,000
-50% -$1.38M 0.16% 208
2022
Q1 		$3.18M Hold
250,000
– – 0.34% 97
2021
Q4 		$5.24M Buy
+250,000
New +$5.05M 0.26% 111

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ghisallo Capital Management's ENFN Position: Q3 2022 in Review

Ghisallo Capital Management sold out of Enfusion, Inc. (ENFN) in Q3 2022, closing a stake of 125,000 shares — an estimated $1.28M sold.

Ghisallo Capital Management first reported a position in ENFN in Q4 2021 and held it in 3 quarters. The position peaked at $5.24M in Q4 2021. 67 funds tracked by Wall St. Rank hold ENFN as of Q3 2022.

  • Ghisallo Capital Management reported no remaining Enfusion, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ghisallo Capital Management sold 125,000 Enfusion, Inc. shares in Q3 2022, an estimated $1.28M.
  • Ghisallo Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 3 quarters.
  • Ghisallo Capital Management's Enfusion, Inc. position peaked at $5.24M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2022.

Based on Ghisallo Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.